Table 2.
Total thoracotomy cases before and during COVID-19 pandemic
| Pre-COVID-19 (n = 55) | During COVID-19 (n = 35) | P value | |||
|---|---|---|---|---|---|
| Age (range), years | 60 (47-66) | 62 (43-67) | |||
| Male/female | 35/20 | 24/11 | |||
| Preoperative oncologic indication, n (% of total) | 43 (78.2) | 29 (82.8) | .32 | ||
| Pathologic diagnosis of malignancy, n (% of total) | 43 | 29 | |||
| Thoracic malignancies, n | 43 | 29 | |||
| Primary lung cancer (n, % malignant cases) | 16 (37.2) | 15 (51.7) | .22 | ||
| T, n (%) | |||||
| T1 | 2 (12.5) | 2 (13.3) | |||
| T2 | 6 (37.5) | 5 (33.3) | |||
| T3 | 6 (37.5) | 4 (26.6) | |||
| T4 | 2 (12.5) | 4 (26.6) | |||
| Pathologic stage, n (%) | |||||
| 0-1 | 4 (25.0) | 3 (20.0) | .74 | ||
| 2 A/B | 7 (43.7) | 5 (33.3) | .19 | ||
| 3-4 | 5 (29.4) | 7 (46.7) | .01 | ||
| Secondary lung cancer and other neoplasms | 26 (60.5) | 14 (48.3) | |||
| Anatomic lung resections, n (% of total) | 19 (34.5) | 20 (57.1) | .05 | ||
| LOS (range), days | 7 (3.5-20.5) | 4 (3.5-7.5) | .39 | ||
| Complications (Clavien–Dindo), n | In-hospital | 30-Day | In-hospital | 30-Day | |
| 0 | 12 | 10 | 13 | 12 | 1.00 |
| 1-2 | 3 | 5 | 4 | 5 | |
| 3-4 | 4 | 4 | 1 | 1 | |
| 5 | 0 | 0 | 2 | 2 | |
| Wedge resection, mediastinal-pleural procedures, n (% of total) | 36 (65.4) | 15 (42.8) | |||
| LOS (range), days | 8 (3-13) | 5 (4-8.7) | .81 | ||
| 30-Day complications (Clavien–Dindo), n | In-hospital | 30-Day | In-hospital | 30-Day | |
| 0 | 25 | 23 | 10 | 9 | 1.00 |
| 1-2 | 7 | 8 | 1 | 2 | |
| 3-4 | 3 | 4 | 3 | 3 | |
| 5 | 1 | 1 | 1 | 1 | |
Data in bold reflect a P value <.05.
COVID-19, Coronavirus disease-19; LOS, length of stay.